Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: J Mol Cell Cardiol. 2010 Oct 28;50(1):107–116. doi: 10.1016/j.yjmcc.2010.10.023

Table 1.

Biometric and echocardiographic properties in lean and ob/ob obese mice with or without chronic TUDCA treatment (50 mg/kg/d for 5 wks; p.o.)

Lean Lean+TUDCA Obese Obese+TUDCA
Body Weight (g) 30.2 ± 0.8 29.5 ± 0.8 59.2 ± 1.6* 55.9 ± 1.0*
Heart Weight (mg) 223 ± 10 193 ± 11 334 ± 19* 222 ± 16*#
HW/BW (mg/g) 7.41 ± 0.43 6.55 ± 0.33 5.66 ± 0.36* 3.98 ± 0.29*#
Liver Weight (g) 1.52 ± 0.06 1.35 ± 0.05 3.96 ± 0.29* 3.61 ± 0.15*
LW/BW (mg/g) 50.5 ± 2.6 46.2 ± 2.2 64.5 ± 2.0 67.1 ± 5.2
Kidney Weight (g) 0.46 ± 0.01 0.37 ± 0.03 0.75 ± 0.03* 0.40 ± 0.03*#
KW/BW (mg/kg) 15.4 ± 0.5 12.6 ± 0.9 12.7 ± 0.5 7.1 ± 0.4*#
Systolic BP (mmHg) 105.6 ± 4.2 100.1 ± 2.3 165.8 ± 9.9* 135.6 ± 5.7*#
Diastolic Diameter (mm) 2.45 ± 0.32 2.49 ± 0.30 3.18 ± 0.36* 2.29 ± 0.23#
Systolic Diameter (mm) 1.31 ± 0.16 1.53 ± 0.27 1.40 ± 0.23 1.22 ± 0.11
Diastolic Wall Thickness (mm) 1.01 ± 0.09 1.17 ± 0.16 1.01 ± 0.05 1.05 ± 0.04
Heart Rate (beat per minute) 462 ± 24 459 ± 32 516 ± 40 573 ± 34
LV Mass (mg) 43.2 ± 6.1 49.2 ± 7.1 88.9 ± 14.5* 63.1 ± 4.5*#
Normalized LV Mass (mg/g) 1.41 ± 0.19 1.59 ± 0.26 1.52 ± 0.29 1.11 ± 0.08
Fractional Shortening (%) 45.2 ± 2.7 42.0 ± 1.5 34.8 ± 4.9* 46.2 ± 1.1#

HW: heart weight; LW: Liver weight; KW: Kidney weight. Mean ± SEM, n = 5–7 mice per group,

*

p < 0.05 vs. lean group;

#

p < 0.05 vs. obese group.